Explore comprehensive CDMO and CMO services offered by Cosette Pharmaceuticals, supporting end-to-end Anlaytical Testing, Drug Development, Manufacturing and Packaging. Cosette Pharmaceuticals enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: U.S.A
Description: Cosette Pharmaceuticals is a US-based, fully integrated pharmaceutical company specializing in women’s health, dermatology, and cardiology. The company is known for manufacturing complex dosage forms such as topical creams, ointments, oral liquids, solutions, and suppositories, with corporate and manufacturing facilities located in New Jersey and North Carolina. Cosette has a growing branded and generic product portfolio, including well-known brands like VYLEESI®, INTRAROSA®, CLOMID®, AMBIEN®, WELCHOL®, and BENICAR®. Backed by Avista Capital Partners and Hamilton Lane, Cosette has expanded rapidly through internal R&D, acquisitions, and strategic partnerships. In 2025, Cosette announced the acquisition of Mayne Pharma, significantly strengthening its leadership in women’s health and dermatology by adding a range of patent-protected and high-growth products, as well as enhancing its commercial and manufacturing capabilities both in the US and internationally. Cosette also provides contract development and manufacturing (CDMO) services for other pharmaceutical companies. - Show More
